Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Titel:
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Auteur:
Xenidis, Nikolaos Vardakis, Nikolaos Varthalitis, Ioannis Giassas, Stylianos Kontopodis, Emmanouel Ziras, Nikolaos Gioulbasanis, Ioannis Samonis, George Kalbakis, Kostas Georgoulias, Vassilis